Artelo Biosciences, Inc. (ARTL) NASDAQ
7.04
-0.8(-10.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.04
-0.8(-10.20%)
Currency In USD
| Market Cap | 2.87M |
| Enterprise Value | 2.97M |
| P/E Ratio | -1.29 |
| PEG Ratio | -0.25 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -13.04 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.6 |
| Return On Equity | 19.37 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -12.54M |
| Net Income | -12.88M |
| Diluted EPS | -5.47 |
| Total Cash | 600,000 |
| Total Cash/Share | 0.25 |
| Total Debt | 693,000 |
| Total Debt/Equity | -0.54 |
| Current Ratio | 0.17 |
| Book Value Per Share | -0.54 |
| 52-Week Change | 36.7 |
| 52-Week High | 85.8 |
| 52-Week Low | 2.96 |
| Moving Average 50 Days | 4.85 |
| Moving Average 200 Days | 14.8 |
| Average Volume | 2.81M |
| Shares Outstanding | 2.12M |
| % Held by Institutions | 3.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | March 10, 2026 |